Utility of type 1 diabetes genetic risk score in a non-European population: insights from an Iranian cohort
Our findings suggest that T1D GRS2, particularly in younger patients, shows promise for improved T1D diagnosis and potentially newborn screening in this population. This could facilitate equitable access to precision medicine approaches for individuals in the area.
Authors
- Mahdi Akbarzadeh (ORCID: https://orcid.org/0000-0002-8048-744X)
- Suad AlFadhli (ORCID: https://orcid.org/0009-0009-8034-6055)
- Amirabbas Momenan (ORCID: https://orcid.org/0000-0001-7339-0693)
- Leila Mahmoudieh
- Sara Asgarian
- Farzad Hadaegh (ORCID: https://orcid.org/0000-0002-0352-8666)
- Asieh Sadat Zahedi
- Hossein Lanjanian (ORCID: https://orcid.org/0000-0003-4284-6592)
- Fereidoun Azizi (ORCID: https://orcid.org/0000-0002-7335-3873)
- Maryam Sadat Daneshpour (ORCID: https://orcid.org/0000-0002-2208-6568)
- Maryam Moazzam-Jazi
- Mehdi Hedayati
- Sajedeh Masjoudi
- Leila Najd Hassan-Bonab
Institutions
- Kuwait University (KW)
- Research Institute for Endocrine Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1186/s13098-025-01776-8
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00